Placental passage of angiotensin-converting enzyme inhibitors

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 5, 1996, Pages 1450-1455

  Reisenberger, K ^a   Egarter, C ^a   Sternberger, B ^a   Eckenberger, P ^a   Eberle, E ^a   Weissenbacher, E R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiotensin converting enzyme inhibitors; fetopathy; perfusion model; placental passage

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; TEMOCAPRIL;

ARTICLE; DRUG CONTRAINDICATION; DRUG MONITORING; DRUG SAFETY; DRUG UPTAKE; HUMAN; HUMAN TISSUE; PLACENTA CIRCULATION; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL;

EID: 0029967286     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70587-2     Document Type: Article

References (20)

1. A Svenson Hypertension in pregnancy Clin Exp Hypertens 15 1993 1353 1361
2. SA Lowe PC Rubin The pharmacological management of hypertension in pregnancy J Hypertens 10 1992 201 207
3. G Valdes D Marinovic C Falcon R Chuaqui I Duarte Placental alterations, intrauterine growth retardation and teratogenicity associated with enalapril use in pregnant rats Biol Neonate 61 1992 124 130
4. G Batastini RN Infurna KIV Wimbert MA Youreneff ET Yau VM Traiana Teratologic evaluation of CGS 16617, an angiotensin converting enzyme inhibiting agent Teratology 37 1988 445
5. H Tsubaki I Mori T Ikeda Determination of metabolites in dam plasma and fetus after CS-622 administration to pregnant rats 1989 Sankyo Tokyo (Report no RAM136-18.)
6. M Barr MM Cohen Ace inhibitor fetopathy and hypocalvaria: the kidney-skull connection Teratology 44 1991 485 495
7. H Schneider A Huch Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentarium Contrib Gynecol Obstet 13 1985 40 47
8. H Schneider M Panigel J Dancis Transfer across the perfused human placenta of antipyrine, sodium and leucine AM J OBSTET GYNECOL 114 1972 822 828
9. MA Sarkar C March HT Karnes Solid phase extraction and simultaneous high performance liquid chromatographic determination of antipyrine and its major metabolites in urine Biomed Chromatogr 6 1992 300 304
10. H Shioya M Shimojo Y Kawahara Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography - mass spectrometry using negative chemical ionization J Chromatogr 496 1989 129 135
11. I Wachter ER Weissenbacher K Schulze F Soergel Study to compare ceftriaxone with cefotane in a human placental perfusion model Int J Exp Clin Chem Ther 5 1992 149 151
12. D Davidson SA Stalcup RB Mellins Captopril administration to the pregnant guinea pig inhibits fetal angiotensin converting enzyme activity Pediatr Res 15 1981 658
13. F Broughton-Pipkin EM Symonds SR Turner The effect of captopril (SQ 14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit J Physiol 323 1982 415 422
14. RL Brent DA Beckman Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors Teratology 43 1991 543 546
15. T Mason MJ Polak L Pyles M Mulett C Swanke Treatment of neonatal renovascular hypertension with intravenous enalapril Am J Perinatol 9 1992 254 257
16. K Weisser J Schloss K Lehmann R Düsing H Vetter E Mutschler Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects Eur J Clin Pharmacol 40 1991 95 99
17. C Cunniff KL Jones J Phillipson K Benirschke S Short J Wujek Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use AM J OBSTET GYNECOL 162 1990 187 189
18. G Schubiger G Flury J Nussberger Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate Arch Intern Med 108 1988 215 216
19. SL Nightingale Warnings on the use of ACE inhibitors in second and third trimester of pregnancy JAMA 267 1992 2445
20. A Shotan J Widerhorn A Hurst U Elkayam Risks of angiotensin-converting-enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use Am J Med 96 1994 451 456